May 29, 2017
In this video, Dr. Srigley talks about the updated CAP protocols for prostate cancer
Watch as Dr. John Srigley talks about the 2017 CAP protocol for carcinoma of the prostate gland, the update on Gleason grading including the prognostic grade groups, the 2016 WHO GU Bluebook, and the updates to AJCC 8th Edition TNM staging for prostate.
John Srigley, MD, is the Chief and Medical Director of the Program of Laboratory Medicine and Genetics at Trillium Health Partners in Mississauga, Ontario, Canada and a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. He also represents Canada on the American Joint Committee on Cancer. In addition to his role as Expert Lead, Pathology, Dr. Srigley is the Chair of the Cancer Care Advisory Committee for the Canadian Association of Pathologists. He graduated from the Faculty of Medicine, University of Toronto, where he also received Anatomical and Ontological training, which he continued at MD Anderson Cancer Center in Houston, Texas, U.S.A.
Watch the video for the CAP education session about prostate cancer
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.